David J Moss insider trades

Open-market stock purchases and sales by David J Moss, Chief Executive Officer at Inmune Bio, Inc, from SEC Form 4 filings since May 5, 2011.

Track record: 0% of 13 scored buys are up 5% or more since purchase, averaging -75%.

Recent trades

DateStockTradeValue
Jul 2, 2026INMB Inmune Bio, IncBought (not open market)$12.6K
Jul 2, 2026INMB Inmune Bio, IncBought (not open market)$1.1K
Dec 1, 2025INMB Inmune Bio, IncBought (not open market)—
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$1M
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$195K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$1.1M
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$335K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$1.6M
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$240K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$3.1M
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$600K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$1.5M
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$89K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$1.1M
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$413K
Nov 18, 2025INMB Inmune Bio, IncSold (not open market)$1.2M
Nov 18, 2025INMB Inmune Bio, IncBought (not open market)$106K

Companies traded

  • INMB Inmune Bio, Inc: 15 buys, 6 sales, last Jul 2, 2026
  • TAEI Tamandare Explorations Inc: 1 buy, last May 5, 2011

Get free alerts when David J Moss files a new trade →